| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |